Genmab Announces Multiple Abstracts to be Presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
Press release content from Business Wire. The AP news staff was not involved in its creation.
Source: apnews.com
📰 Single Slides News
Single Slides News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Single Slides. Real-time updates on events, politics, business and more.
2022-05-26 | NDAQ:GMAB | Press Release
(2022-05-26 | NDAQ:GMAB) Genmab Announces Multiple Abstracts to be Presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
Source: stockhouse.com
Genmab Announces Multiple Abstracts to be Presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
Multiple epcoritamab (DuoBody-CD3xCD20) poster presentations highlighting data in a variety of treatment settings and hematologic malignancies Oral presentation of tisotumab vedotin first-line
Source: finanznachrichten.de